Angiogenesis is a fundamental biological process by which new capillary blood vessels are formed. Targeting angiogenesis has become a popular pharmacology strategy employed by the pharmaceutical industry and several companies are estimated to be involved in the race to develop angiogenesis-based medicines. This article focuses on the grade of angiogenesis market in magnetizing key players and high-profile deals and the deal making trends in angiogenesis.